( ARTG ) Adjuvant treatment of resected non-small cell lung cancer,Alecensa is indicated as adjuvant treatment in adult patients following tumour resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours equal to or greater than 4 cm or node positive).,Treatment of metastatic NSCLC,Alecensa is indicated for the treatment of patients with A

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

OTC

HealthdirectFree Australian health advice you can count on.

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Roche Pharma (Schweiz) AG (CH)

ATC Code

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.